K-numberK243680
Device nameNeurovascular Insight V1.0
ApplicantOlea Medical S.A.S.
Product codeLLZ
Device classClass II
Decision dateAug 25, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Neurovascular Insight V1.0 is an optional user interface for viewing and processing neurological DICOM medical images (MR and CT studies) on a compatible technical integration environment. It allows trained medical professionals to display images, edit and modify processing parameters, and confirm/export outputs from compatible applications without altering the original image data. The device is not intended as a diagnostic tool but to assist clinicians in medical imaging assessment.

Technological characteristics

Both the subject device and predicate provide identical core tools: MR and CT image loading and visualization, standard viewing tools, 3D MIP visualization, manual side selection, and manual AIF/VOF selection. The minor difference is that Neurovascular Insight V1.0 adds the capability to manually select ASPECTS regions and confirm information before displaying outputs and exporting them—a feature already cleared in the reference CINA-ASPECTS device for the same intended use.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Substantial equivalence is supported by three factors: (1) substantially equivalent intended use—both devices visualize MR and CT studies and allow parameter editing in clinical environments by trained professionals; (2) equivalent technological characteristics—both provide the same core viewing and editing tools, with the subject device's added confirmation feature already validated in a cleared reference device; and (3) adequate verification and validation testing—internal software testing, risk assessment, and usability testing confirmed the subject device meets specifications and performs comparably to the predicate, with no new safety or effectiveness questions raised by the minor technological differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →